1. K.
Park and D.Z. D'Argenio. Stochastic control
of pharmacodynamic processes with application
to ergotamine. In D.Z. D'Argenio (ed.),
Advanced Methods of Pharmacokinetic and
Pharmacodynamic Systems Analysis, Vol. 2,
Plenum Press, New York, pp. 189-204, 1995
2. D.Z. D'Argenio and K. Park. Uncertain
pharmacokinetic/ pharmacodynamic systems:
Design, estimation and control. Control
Eng. Practice 5:1707-1716, 1997
3. K. Park, D. Verotta, T.F. Blaschke and
L.B. Sheiner. A semiparametric method for
describing noisy population pharmacokinetic
data. J. Pharmacokin. Biopharm. 25: 615-642,
1997
4. G.F. Vanhove, H. Kastrissios, J.M. Gries,
D. Verotta, K. Park, A.C. Collier, K Squires,
L.B. Sheiner, and T.F. Blaschke. Pharmacokinetics
of saquinavir, zidovudine, and zalcitabine
in combination therapy. Antimicrob. Agents
Chemother 41:2428-32, 1997
5. K. Park, D. Verotta, S.K. Gupta and
L.B. Sheiner. Passive versus electrotransport-facilitated
transdermal absorption of ketorolac. Clin.
Pharmacol. Ther. 63:303-315, 1998
6. K. Park, D. Verotta, S.K. Gupta and
L.B. Sheiner. Use of a pharmacokinetic/pharmacodynamic
model to design an optimal dose input profile.
J. Pharmacokin. Biopharm. 26: 471-492, 1998
7. M.E. Krecic-Shepard, K. Park, C. Barnas,
J. Slimko, D.R. Kerwin and J.B. Schwartz.
Race and sex influence clearance of nifedipine:
Results of a population study. Clin. Pharmacol.
Ther. 68: 130-42, 2000
8. K. Park and D.Z. D'Argenio. Control
of Uncertain Pharmacodynamic Systems. In
D.Z. D'Argenio (ed.), Advanced Methods of
Pharmacokinetic and Pharmacodynamic Systems
Analysis, Vol. 3, Kluwer Academic Publishers,
Norwell, MA, pp. 275-293, 2004
9. K. Park, E. J. Hur, K. W. Han, H. Y.
Kil, T. H. Han, Bispectral Index Does Not
Correlate With Observer Assessment of Alertness
and Sedation Scores During 0.5% Bupivacaine
Epidural Anesthesia with Nitrous Oxide Sedation,
Anesth Analg 103(2):385-9, 2006
10. K. Park, Y. S. Kim, K. I. Kwon, M.
S. Park, Y. J. Lee, K. H. Kim, A Randomized,
Open-Label, Two-Period, Crossover Bioavailability
Study of Two Oral Formulations of Tacrolimus
in Healthy Korean Adults. Clin Ther 29(1):
154-162, 2007
11. J. H. Choi, Y. J. Lee, S. B. Jang,
J. E. Lee, K. H. Kim, K. Park. Influence
of the CYP3A5 and MDR1 genetic polymorphisms
on the pharmacokinetics of tacrolimus in
healthy Korean subjects. Br J Clin Pharmacol
64(2): 185-191, 2007
12. J. H. Choi, M. G. Lee, J. Y. Cho, J.
E. Lee, K. H. Kim, K. Park, Influence of
OATP1B1 genotype on the pharmacokinetics
of rosuvastatin in Koreans. Clin. Pharmacol.
Ther. 83(2): 251-257, 2008
13. J. H. Sohn, H. J. Choi, J. T. Lee,
J. D. Lee, J. H. Kim, Y. M. Moon, K. Park,
K. B. Park, E. Kim, N. C. Yoo, Phase II
study of transarterial holmium-166-chitosan
complex in patients with a single, large
hepatocellular carcinoma. Oncology 76(1):
1-9, 2009
14. Sohn JH, Choi
HJ, Lee JT, Lee JD, Kim JH, Moon YM, Park
K, Park KB, Kim E, Yoo NC: Phase II study
of transarterial Holmium-166-chitosan complex
treatment in patients with a single, large
hepatocellular carcinoma. Oncology 76: 1-9,
2009
15 . Kim HC,
Cho YJ, Ahn CW, Park K, Kim JC, Nam JS,
Im YS, Lee JE, Lee SC, Lee HK: Nerve growth
factor and expression of its receptors in
patients with dibetic neuropathy. Diabetic
Medicine 26(12): 1228-1234, 2009
16 . Yim YS, Choi
JS, Jang SB, Kim GT, Park K, Kim CH, Cheon
JW, Kim DG: Pharmacokinetic properties and
tissue storage of FITC conjugated SA-MnMEIO
nanoparticles in mice. Current Applied Physics
9: e304-e307, 2009
17 . Jang SB, Lee
YJ, Lim LA, Park KM, Kwon BJ, Woo JS, Kim
YI, Park MS, Kim KH, Park K: Pharmacokinetic
comparison of controlled-release and immediate-release
oral formulations of simvastatin in healthy
korean subjects: A randomized, open-label,
parallel-group, single- and multiple-dose
study. Clinical Therapeutics 32(1): 206-216,
2010
|
